Q32 Bio share price logo

Q32 Bio

NASDAQ: QTTB

Small Cap

$10.62

-0.24

(-2.21%)

Live

as on

Q32 Bio Stock Performance

as on September 19, 2026 at 5:07 am IST

  • Day's Low

    Day's High

    $10.60
    $10.97
    downward going graph

    0.19%

    Downside

    3.30%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.69
    $23.57
    downward going graph

    84.09%

    Downside

    121.94%

    Upside

    downward going graph

Q32 Bio share price movements today

Previous Close
$10.86
Open
$10.84
Volume
184.6K
Market Cap
$323.3M
Day's Low - High
$10.60 - $10.97
52 Week Low - High
$1.69 - $23.57

Q32 Bio Historical Returns

1 Month Return
-28.97 %
3 Month Return
-8.74 %
1 Year Return
+ 524.14 %
3 Year Return
0 %
5 Year Return
0 %

Q32 Bio Stock Fundamentals & Key Indicators

Check Q32 Bio market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$323.3M

EPS (TTM)

2.79

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

3.89

Industry PE ratio

-6.87

PEG Ratio

0.014496407081128733

EBITDA

34.6M

Revenue (TTM)

53.7M

Profit Margin

99.84%

Return On Equity TTM

76.88%

Q32 Bio Stock Valuation

Track how Q32 Bio P/E has moved over time to understand its valuation trends.

Q32 Bio in the last 5 years

  • Overview

  • Trends

Lowest (-2.10x)

December 31, 2021

Industry (-6.87x)

December 31, 2025

Today (1.37x)

December 31, 2025

Highest (1.37x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: 1.37x

Q32 Bio vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Q32 Bio with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$323.3MNA3.8999.84%0.00%
BUY$63.1B-63.24%-19.81-12.57%0.00%
BUY$130.1B174.21%29.8186.04%0.00%
BUY$79.7B21.1%18.4884.86%0.48%

Stock Returns calculator for Q32 Bio Stock including INR - Dollar returns

The Q32 Bio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Q32 Bio investment value today

Current value as on today

₹6,63,393

Returns

₹5,63,393

(+563.39%)

Returns from Q32 Bio Stock

₹5,10,345 (+510.34%)

Dollar Impact

₹53,049 (+53.05%)

Analyst Recommendation on Q32 Bio Stock

Based on 5 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 5 analysts, 100% of analysts recommend a 'BUY' rating for Q32 Bio. Average target price of $42.25

Q32 Bio Share Price Target

Get share price movements and forecasts by analysts on Q32 Bio.

What analysts predicted

74.86%UPSIDE

Target Price

$42.25

Current Price

$10.62

Analyzed by

5 Analysts

Target

$42.25

Q32 Bio target price $42.25, a slight upside of 74.86% compared to current price of $10.62. According to 5 analysts rating.

Indian Investors' Interest in Q32 Bio Stock

Search interest for Q32 Bio Stock has decreased by -4% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-4% versus previous 30 day period

Q32 Bio Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
53
-
-
Gross Profit
-
-
-
-
-
-
-
53
-
0
Operating Income
-14
-17
-18
-14
-12
-9
-7
45
-7
-9
EBITDA
-14
-17
-17
6
-12
-9
-6
58
-7
-8
Interest Expense
-
-
0
-
0
0
0
0
-
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
1
-16
-17
-14
-11
-9
-7
57
-7
-8
Income Tax Expense
0
-
-
0
-
-
-
-
-
-
Net Income
1
-16
-17
-14
-11
-9
-7
57
-7
-8
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
100.00%
0.00%
0.00%

Q32 Bio Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
5
1
2
-
6
-6
-
53
Gross Profit
0
5
1
-
-
6
-6
-
53
Operating Income
-29
-59
-109
-130
-36
-39
-48
-66
16
EBITDA
-29
-58
-97
-121
-36
-38
-47
-44
31
Interest Expense
-
-
-
-
-
-
-
1
1
Depreciation
0
1
6
8
0
0
0
0
0
Income Before Tax
-29
-55
-103
-128
-37
-42
-53
-47
29
Income Tax Expense
0
-
-
-
0
0
0
0
-
Net Income
-29
-55
-103
-128
-37
-42
-53
-47
29
Net Profit Margin
0.00%
100.00%
100.00%
100.00%
71.91%
100.00%
100.00%
0.00%
100.00%

Q32 Bio Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
1
-16
-17
-14
-11
-9
-7
57
-7
-8
Operating Cash Flow
-14
-22
-19
-11
-12
-10
-4
-6
-6
-3
Investing Cash Flow
0
9
9
0
-
-
-
7
-
-
Financing Cash Flow
99
-5
0
0
-
-
-1
-1
8
58
Change in Cash
84
-17
-8
-11
-12
-10
-5
0
2
55

Q32 Bio Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-29
-55
-103
-128
-95
-42
-53
-47
29
Operating Cash Flow
6
-42
-91
-94
-109
-10
-18
-67
-33
Investing Cash Flow
-81
-121
-51
204
-50
-2
0
19
7
Financing Cash Flow
115
150
158
53
52
30
0
95
-3
Change in Cash
40
-13
15
163
-109
16
-8
47
-29

Mutual Funds that own Q32 Bio Stock

Check out the Mutual Funds with significant holdings in Q32 Bio.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
1.029245%
306401
Fidelity Concord Street Trust
0.315917%
94047
Fidelity Commonwealth Trust II
0.13797%
41073
Bridgeway Funds, Inc.
0.042368%
12613
Victory Portfolios III
0.015569%
4635

Global Institutional Holdings in Q32 Bio

Funds
Holdings
Peter Kolchinsky
7.84%
Vanguard
2.94%
Avantis
2.03%
Michael Rockefeller
0.96%
Dimensional
0.21%

Q32 Bio News & Key Events

  • img

    Today's Timeline - 13 July

    Mon, 06:31 AM

    -

    Q32 Bio announces $200M stock and warrant offering to fund clinical development and commercialization efforts.

    Mon, 06:25 PM

    -

    Q32 Bio shares rise sharply in pre-market trading ahead of 36-week topline results from SIGNAL-AA Phase 2a clinical trial.

    Tue, 01:31 AM

    -

    Q32 Bio reports positive results for bempikibart in alopecia areata, showing significant hair regrowth and favorable safety profile.

Insights on Q32 Bio

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, QTTB stock has moved up by 524.1%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, QTTB has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, -14.66M → 53.73M (in $), with an average increase of 127.3% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 57.73M → -8.94M (in $), with an average decrease of 65.4% per quarter

About Q32 Bio

Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human anti"interleukin-7 receptor alpha antagonist monoclonal antibody which completed Phase 2a clinical trials, designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb " CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition and a range of other indications. The company was founded in 2017 and is based in Waltham, Massachusetts.
OrganisationQ32 Bio
Headquarters830 Winter Street, Waltham, MA, United States, 02451
IndustryBiotechnology
CEOMs. Jodie Pope Morrison
E-voting on sharesClick here to vote

Key Management of Q32 Bio

Name

Title

Ms. Jodie Pope Morrison

CEO & Director

Mr. Lee H. Kalowski M.B.A.

CFO & President

Dr. Shelia M. Violette Ph.D.

Co-founder, Chief Scientific Officer & President of Research

Mr. David Appugliese J.D.

Senior VP & Head of People

Ms. Maria Marzilli M.P.H.

Chief Business Officer

FAQs

What is Q32 Bio share price today?

Q32 Bio share price today is $10.62 as on . Q32 Bio share today touched a day high of $10.97 and a low of $10.60.

What is the 52 week high and 52 week low for Q32 Bio share?

Q32 Bio share touched a 52 week high of $23.57 on and a 52 week low of $1.69 on . Q32 Bio stock price today i.e. is trending at $10.62,which is 54.94% down from its 52 week high and 528.40% up from its 52 week low.

What is Q32 Bio's market capitalisation today?

Q32 Bio market capitalisation is $0.00T as on .

How to invest in Q32 Bio Stock (QTTB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Q32 Bio on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Q32 Bio Shares that will get you 0.1412 shares as per Q32 Bio share price of $10.62 per share as on September 18, 2026 at 11:37 pm IST.

What is the minimum amount required to buy Q32 Bio Stock (QTTB) from India?

Indian investors can start investing in Q32 Bio (QTTB) shares with as little as ₹95.8725 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.73 in Q32 Bio stock (as per the Rupee-Dollar exchange rate as on ). Based on Q32 Bio share’s latest price of $10.62 as on September 18, 2026 at 11:37 pm IST, you will get 0.9416 shares of Q32 Bio. Learn more about fractional shares .